Cypress Capital Group Abbott Laboratories Transaction History

Cypress Capital Group

$797 Million
Q4 2024

A detailed history of Cypress Capital Group transactions in Abbott Laboratories stock. As of the latest transaction made, Cypress Capital Group holds 73,476 shares of ABT stock, worth $9.91 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

73,476

Previous 76,648 4.14%

Holding current value

$9.91 Million

Previous $8.74 Million 4.9%

% of portfolio

1.04%

Previous 0.99%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$111.93 - $119.39 $355,041 - $378,705	-3,172 Reduced 4.14%	73,476 $8.31 Million
Q3 2024 Nov 08, 2024	SELL	$100.07 - $118.13 $74,051 - $87,416	-740 Reduced 0.96%	76,648 $8.74 Million
Q2 2024 Jul 25, 2024	SELL	$100.73 - $112.44 $70,208 - $78,370	-697 Reduced 0.89%	77,388 $8.04 Million
Q1 2024 May 08, 2024	BUY	$109.52 - $120.96 $8,214 - $9,072	75 Added 0.1%	78,085 $8.88 Million
Q4 2023 Jan 24, 2024	SELL	$90.19 - $110.4 $214,381 - $262,420	-2,377 Reduced 2.96%	78,010 $8.59 Million
Q3 2023 Nov 02, 2023	BUY	$95.53 - $114.62 $23,213 - $27,852	243 Added 0.3%	80,387 $7.79 Million
Q2 2023 Jul 26, 2023	SELL	$100.78 - $112.29 $150,363 - $167,536	-1,492 Reduced 1.83%	80,144 $8.74 Million
Q1 2023 May 04, 2023	SELL	$96.86 - $114.01 $1.02 Million - $1.2 Million	-10,561 Reduced 11.45%	81,636 $8.27 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $198,770 - $233,188	-2,091 Reduced 2.22%	92,197 $10.1 Million
Q3 2022 Nov 04, 2022	SELL	$96.76 - $112.03 $623,714 - $722,145	-6,446 Reduced 6.4%	94,288 $9.12 Million
Q2 2022 Jul 26, 2022	SELL	$102.07 - $123.37 $720,614 - $870,992	-7,060 Reduced 6.55%	100,734 $10.9 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $12.3 Million - $15 Million	107,794 New	107,794 $12.8 Million
Q4 2021 Feb 15, 2022	SELL	$115.53 - $141.46 $12.1 Million - $14.9 Million	-104,985 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$116.66 - $129.06 $59,379 - $65,691	509 Added 0.49%	104,985 $12.4 Million
Q2 2021 Jul 13, 2021	SELL	$105.79 - $124.53 $99,231 - $116,809	-938 Reduced 0.89%	104,476 $12.1 Million
Q1 2021 Apr 14, 2021	SELL	$108.84 - $128.23 $66,936 - $78,861	-615 Reduced 0.58%	105,414 $12.6 Million
Q4 2020 Jan 12, 2021	BUY	$105.0 - $114.42 $153,405 - $167,167	1,461 Added 1.4%	106,029 $11.6 Million
Q3 2020 Oct 08, 2020	BUY	$91.64 - $111.29 $25,750 - $31,272	281 Added 0.27%	104,568 $11.4 Million
Q2 2020 Jul 10, 2020	SELL	$76.57 - $98.0 $241,118 - $308,602	-3,149 Reduced 2.93%	104,287 $9.54 Million
Q1 2020 Apr 08, 2020	SELL	$62.82 - $91.86 $99,067 - $144,863	-1,577 Reduced 1.45%	107,436 $8.48 Million
Q4 2019 Jan 10, 2020	SELL	$78.51 - $87.4 $94,918 - $105,666	-1,209 Reduced 1.1%	109,013 $9.47 Million
Q3 2019 Oct 10, 2019	SELL	$81.84 - $88.74 $94,525 - $102,494	-1,155 Reduced 1.04%	110,222 $9.22 Million
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $11,296 - $13,175	-155 Reduced 0.14%	111,377 $9.37 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $127,473 - $154,115	-1,925 Reduced 1.7%	111,532 $8.92 Million
Q4 2018 Feb 19, 2019	BUY	$65.56 - $74.27 $132,103 - $149,654	2,015 Added 1.81%	113,457 $8.21 Million
Q3 2018 Nov 15, 2018	BUY	$60.81 - $73.36 $187,720 - $226,462	3,087 Added 2.85%	111,442 $8.18 Million
Q2 2018 Aug 15, 2018	BUY	$57.57 - $63.54 $1.94 Million - $2.14 Million	33,665 Added 45.07%	108,355 $6.61 Million
Q1 2018 May 21, 2018	SELL	$56.27 - $63.62 $47,942 - $54,204	-852 Reduced 1.13%	74,690 $4.48 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $187,557 - $200,800	-3,494 Reduced 4.42%	75,542 $4.31 Million
Q2 2017 Aug 15, 2017	BUY	N/A	79,036	79,036 $3.84 Million

Others Institutions Holding ABT

# of Institutions

3,361

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Account

Cypress Capital Group Abbott Laboratories Transaction History